Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival
- PMID: 19453367
- DOI: 10.1111/j.1476-5829.2009.00185.x
Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival
Abstract
The purpose of this retrospective cohort study is to describe the association of cytological assessment of lymph node metastasis with survival and tumour grade in dogs with mast cell tumours. Regional lymph node aspirates of 152 dogs diagnosed with a mast cell tumour were reviewed and classified according to specific cytological criteria for staging. 97 dogs (63.8%) had stage I tumours, and 55 (36.2%) had stage II tumours. Stage II dogs had a significantly shorter survival time than dogs with stage I disease (0.8 and 6.2 years, respectively; P < 0.0001). Dogs with grade III mast cell tumours were more likely to have stage II disease (P = 0.004). These results suggest that cytological evaluation of lymph nodes in dogs with mast cell tumours provides useful and valuable clinical information, and the results correlate with tumour grade and outcome thus providing a practical and non-invasive method for staging.
Similar articles
-
Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.J Small Anim Pract. 2009 Jun;50(6):284-9. doi: 10.1111/j.1748-5827.2009.00732.x. J Small Anim Pract. 2009. PMID: 19527421
-
Correlation of nodal mast cells with clinical outcome in dogs with mast cell tumour and a proposed classification system for the evaluation of node metastasis.J Comp Pathol. 2014 Nov;151(4):329-38. doi: 10.1016/j.jcpa.2014.07.004. Epub 2014 Aug 27. J Comp Pathol. 2014. PMID: 25172053
-
Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.J Vet Med A Physiol Pathol Clin Med. 2005 Aug;52(6):280-6. doi: 10.1111/j.1439-0442.2005.00726.x. J Vet Med A Physiol Pathol Clin Med. 2005. PMID: 16050909
-
A review of sentinel lymph node evaluation and the need for its incorporation into veterinary oncology.Vet Comp Oncol. 2009 Jun;7(2):81-91. doi: 10.1111/j.1476-5829.2009.00183.x. Vet Comp Oncol. 2009. PMID: 19453362 Review.
-
Advances in the diagnosis and management of cutaneous mast cell tumours in dogs.J Small Anim Pract. 2007 Aug;48(8):424-31. doi: 10.1111/j.1748-5827.2007.00366.x. Epub 2007 Jun 9. J Small Anim Pract. 2007. PMID: 17559522 Review.
Cited by
-
Indirect lymphography for sentinel lymph node detection in dogs with mast cell tumors.Can Vet J. 2023 Feb;64(2):142-148. Can Vet J. 2023. PMID: 36733656 Free PMC article.
-
Canine mast cell tumors: diagnosis, treatment, and prognosis.Vet Med (Auckl). 2014 Aug 12;5:49-58. doi: 10.2147/VMRR.S41005. eCollection 2014. Vet Med (Auckl). 2014. PMID: 32670846 Free PMC article. Review.
-
A systematic review of surgical margins utilized for removal of cutaneous mast cell tumors in dogs.BMC Vet Res. 2020 Jan 6;16(1):5. doi: 10.1186/s12917-019-2227-8. BMC Vet Res. 2020. PMID: 31906934 Free PMC article.
-
Combination vinblastine, prednisolone and toceranib phosphate for treatment of grade II and III mast cell tumours in dogs.Vet Med Sci. 2018 May 24;4(3):237-51. doi: 10.1002/vms3.106. Online ahead of print. Vet Med Sci. 2018. PMID: 29797551 Free PMC article.
-
Retrospective Analysis of Clinical Presentation, Prognostic Factors and Outcome in 32 Dogs with Subcutaneous Mast Cell Tumours Treated with a Curative-Intent Approach.Vet Med Sci. 2025 Mar;11(2):e70291. doi: 10.1002/vms3.70291. Vet Med Sci. 2025. PMID: 40028787 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources